Protara Therapeutics Q3 Net Loss Widens on Higher Expenses
OverviewOutlookResult DriversCompany press release:Key DetailsReuters Recommended ReadsFor questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.(This story was created using Reuters automati…
Story updates
01:13:28 PM UTC
SquawkNews
Protara Therapeutics reported a net loss of $21.7 million, or $0.35 per share, for the third quarter of 2026, compared with a net loss of $13.3 million, or $0.31 per share, a year earlier. Cash, cash equivalents and marketable debt securities totaled $143.1 million at September 30, 2026, which the…
OverviewOutlookResult DriversCompany press release:Key DetailsReuters Recommended ReadsFor questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.(This story was created using Reuters automati…